164 The association between neurotrophic tropomycin receptor kinase (NTRK) variants of unknown significance (VUS’s) and response to immune checkpoint inhibitors in solid tumors

• Belal Firwana,
• Andreas Seeber,
• Moh’d Khushman,
• Upender Manne,
• Michael Iglesia,
• Kilannin Krysiak,
• Lulu Sun

Affiliations

Belal Firwana

Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA

Andreas Seeber

Medical University of Innsbruck, Innsbruck, Austria

Moh’d Khushman

5Washington University in St. Louis, St. Louis, MO, USA

Upender Manne

Pathology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA

Michael Iglesia

1Washington University in St. Louis, St. Louis, MO, USA

Kilannin Krysiak

1Washington University in St. Louis, St. Louis, MO, USA

Lulu Sun

1Washington University in St. Louis, St. Louis, MO, USA